BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27005968)

  • 1. Application of cancer-associated glycoforms and glycan-binding probes to an in vitro diagnostic multivariate index assay for precise diagnoses of cancer.
    Kang JG; Ko JH; Kim YS
    Proteomics; 2016 Dec; 16(24):3062-3072. PubMed ID: 27005968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylation markers in cancer.
    Silsirivanit A
    Adv Clin Chem; 2019; 89():189-213. PubMed ID: 30797469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma.
    Norton P; Comunale MA; Herrera H; Wang M; Houser J; Wimmerova M; Romano PR; Mehta A
    Proteomics; 2016 Dec; 16(24):3126-3136. PubMed ID: 27650323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of lectin microarrays in cancer diagnosis.
    Syed P; Gidwani K; Kekki H; Leivo J; Pettersson K; Lamminmäki U
    Proteomics; 2016 Apr; 16(8):1257-65. PubMed ID: 26841254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein biomarkers in cancer: natural glycoprotein microarray approaches.
    Zhao J; Patwa TH; Lubman DM; Simeone DM
    Curr Opin Mol Ther; 2008 Dec; 10(6):602-10. PubMed ID: 19051138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant Lectins Targeting O-Glycans at the Cell Surface as Tools for Cancer Diagnosis, Prognosis and Therapy.
    Poiroux G; Barre A; van Damme EJM; Benoist H; Rougé P
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28598369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-glycosylation of fibrinogen from different mammalian species as revealed by the binding of Escherichia coli biotinylated lectins.
    L'Hôte C; Berger S; Karamanos Y
    Thromb Haemost; 1996 Nov; 76(5):710-4. PubMed ID: 8950778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoprotein disease markers and single protein-omics.
    Chandler K; Goldman R
    Mol Cell Proteomics; 2013 Apr; 12(4):836-45. PubMed ID: 23399550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concept, strategy and realization of lectin-based glycan profiling.
    Hirabayashi J
    J Biochem; 2008 Aug; 144(2):139-47. PubMed ID: 18390573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-translational modifications in tumor biomarkers: the next challenge for aptamers?
    Díaz-Fernández A; Miranda-Castro R; de-Los-Santos-Álvarez N; Lobo-Castañón MJ
    Anal Bioanal Chem; 2018 Mar; 410(8):2059-2065. PubMed ID: 29353432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cadherins Glycans in Cancer: Sweet Players in a Bitter Process.
    Carvalho S; Reis CA; Pinho SS
    Trends Cancer; 2016 Sep; 2(9):519-531. PubMed ID: 28741480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.
    Chugh S; Gnanapragassam VS; Jain M; Rachagani S; Ponnusamy MP; Batra SK
    Biochim Biophys Acta; 2015 Dec; 1856(2):211-25. PubMed ID: 26318196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lectin biosensors in cancer glycan biomarker detection.
    Silva MLS
    Adv Clin Chem; 2019; 93():1-61. PubMed ID: 31655728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycans as cancer biomarkers.
    Adamczyk B; Tharmalingam T; Rudd PM
    Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aglycosylated antibody-producing mice for aglycosylated antibody-lectin coupled immunoassay for the quantification of tumor markers (ALIQUAT).
    Lee NE; Kim SH; Yu DY; Woo EJ; Kim MI; Seong GS; Lee SM; Ko JH; Kim YS
    Commun Biol; 2020 Oct; 3(1):636. PubMed ID: 33128033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass Spectrometry-Based N-Glycomics of Colorectal Cancer.
    Sethi MK; Fanayan S
    Int J Mol Sci; 2015 Dec; 16(12):29278-304. PubMed ID: 26690136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant glycosylation as biomarker for cancer: focus on CD43.
    Tuccillo FM; de Laurentiis A; Palmieri C; Fiume G; Bonelli P; Borrelli A; Tassone P; Scala I; Buonaguro FM; Quinto I; Scala G
    Biomed Res Int; 2014; 2014():742831. PubMed ID: 24689054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities.
    Tang H; Hsueh P; Kletter D; Bern M; Haab B
    Adv Cancer Res; 2015; 126():167-202. PubMed ID: 25727148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New development of glycan arrays.
    Wu CY; Liang PH; Wong CH
    Org Biomol Chem; 2009 Jun; 7(11):2247-54. PubMed ID: 19462030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piezoelectric printing and probing of Lectin NanoProbeArrays for glycosylation analysis.
    Nagaraj VJ; Eaton S; Thirstrup D; Wiktor P
    Biochem Biophys Res Commun; 2008 Oct; 375(4):526-30. PubMed ID: 18718447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.